Rationale and design of multicenter prospective observational study of types, GRAde, VariabilITY, associations and prognosis of orthostatic responses in Heart Failure (GRAVITY-HF)
https://doi.org/10.15829/1560-4071-2020-1-3662
Abstract
Heart failure (HF) is one of the leading causes of adult mortality. Increased risk of death determines need for better understanding of the pathophysiological mechanisms, predictive risk stratification models and applicable methods to improve prognosis. One of the unfavorable prognostic factors may be an inadequate hemodynamic response to orthostatic stress. Orthostatic hypotension (OH) is known to be an independent predictor of many cardiovascular diseases, particularly HF, and death. Singlecenter study of HF population revealed that systolic blood pressure within 3-5 minutes after standing up may be a predictor of long-term unfavorable outcomes. Nevertheless, data about OH in patients with HF are limited and inconsistent due to heterogeneity of populations and different methodology in published studies. In this regard, a population-based study of the orthostatic response in patients with HF (stable and decompensated) is needed. The article describes the rationale and design of a multicenter prospective observational study aimed to assess the clinical and prognostic significance of orthostatic responses in HF patients.
About the Authors
E. V. ShlyakhtoSt. Petersburg
S. V. Villevalde
St. Petersburg
A. E. Soloveva
Russian Federation
St. Petersburg
N. E. Zvartau
St. Petersburg
M. Yu. Sitnikova
St. Petersburg
D. N. Fedorova
St. Petersburg
N. G. Vinogradova
Nizhny Novgorod
I. V. Fomin
Nizhny Novgorod
References
1. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics 2018 update: A report from the American Heart Association. Circulation. 2018;137(12):E67E492. doi:10.1161/CIR.0000000000000558.
2. He idenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the united states a policy statement from the american heart association. Circ Hear Fail. 2013;6(3):606-19. doi:10.1161/HHF.0b013e318291329a.
3. Ricci F, Fedorowski A, Radico F, et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J. 2015;36(25):1609-17. doi:10.1093/eurheartj/ehv093.
4. Juraschek SP, Daya N, Appel LJ, et al. Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle‐Aged Adults. J Am Heart Assoc. 2018;7(10). doi:10.1161/JAHA.118.008884.
5. Min M, Shi T, Sun C, et al. Orthostatic hypotension and the risk of atrial fibrillation and other cardiovascular diseases: An updated meta‐analysis of prospective cohort studies. J Clin Hypertens. 2019;21(8):1221-7. doi:10.1111/jch.13613.
6. Prokopova LV, Sitnikova MY. Calculator “Available prognosis”: Method of evaluation for predicting survival of patients with chronic heart failure and reduced left ventricular ejection fraction. Kardiologiia. 2018;58(5S):30-36. (In Russ.) https://doi.org/10.18087/cardio.2438.
7. Sitnikova MY, Bortsova MA, Galenko VL, et al. Continuum stages for prognosis improvement in different subgroups of heart failure patients: from the organization of management and optimization of physical rehabilitation program to specification of risk factors. Translational Medicine. 2015;(5):62-72. (In Russ.) doi:10.18705/2311-4495-2015-0-5-62-72.
8. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810-52. doi:10.1161/CIR.0b013e31829e8807.
9. Mareev VY, Fomin O V, Ageev FT, et al. Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: Chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiya. 2018;58:8-164. (In Russ.) doi:10.18087/cardio.2475.
10. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. doi:10.1002/ejhf.592.
11. Golovina GA, Duplyakov DV. Orthostatic hypotension: the cardiologist’s view. “Arterial’naya Gipertenziya” (“Arterial Hypertension”). 2014;20(2):75-85. (In Russ.) doi:10.18705/1607-419x-2014-20-2-75-85.
12. Gorelik O, Feldman L, Cohen N. Heart failure and orthostatic hypotension. Heart Fail Rev. 2016;21(5):529-38. doi:10.1007/s10741-016-9541-z.
13. Bortsova MA, Sitnikova MY, Dorofeykov VV, et al. Circadian blood pressure profile and different diuretic therapy regimens in patients with severe chronic heart failure: effects on natriuretic peptide levels. Russian Journal of Cardiology. 2009;(3):57-62. (In Russ.) doi:10.15829/1560-4071-2009-3-57-62.
14. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72. doi:10.1007/s10286-011-0119-5.
15. Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society ofHypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESCTask Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. doi:10.1097/HJH.0b013e328364ca4c.
16. Williams B, Masera G. 2018 ESC / ESH Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;39(33):3021-104. doi:10.1093/eurheartj/ehy339.
17. Strogatz DS, Keenan NL, Barnett EM, et al. Correlates of Postural Hypotension in a Community Sample of Elderly Blacks and Whites. J Am Geriatr Soc. 1991;39(6):562-6. doi:10.1111/j.1532-5415.1991.tb03593.x.
18. Shin C, Abbott RD, Lee H, et al. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: The Korean Health and Genome Study. J Hum Hypertens. 2004;18(10):717-23. doi:10.1038/sj.jhh.1001732.
19. Raiha I, Luutonen S, Piha J, et al. Prevalence, Predisposing Factors, and Prognostic Importance of Postural Hypotension. Arch Intern Med. 1995;155(9):930-5. doi:10.1001/archinte.1995.00430090067008.
20. Fedorowski A, Burri P, Melander O. Orthostatic hypotension in genetically related hypertensive and normotensive individuals. J Hypertens. 2009;27(5):976-82. doi:10.1097/HJH.0b013e3283279860.
21. Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567-82. doi:10.1007/s00415016-8375-x.
Review
For citations:
Shlyakhto E.V., Villevalde S.V., Soloveva A.E., Zvartau N.E., Sitnikova M.Yu., Fedorova D.N., Vinogradova N.G., Fomin I.V. Rationale and design of multicenter prospective observational study of types, GRAde, VariabilITY, associations and prognosis of orthostatic responses in Heart Failure (GRAVITY-HF). Russian Journal of Cardiology. 2020;25(1):3662. (In Russ.) https://doi.org/10.15829/1560-4071-2020-1-3662